Neuronal apoptosis inhibitory protein is implicated in amyotrophic lateral sclerosis symptoms
出版年份 2018 全文链接
标题
Neuronal apoptosis inhibitory protein is implicated in amyotrophic lateral sclerosis symptoms
作者
关键词
-
出版物
Scientific Reports
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-01-02
DOI
10.1038/s41598-017-18627-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- (2017) Koji Abe et al. LANCET NEUROLOGY
- Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis
- (2017) Christian Lunetta et al. JAMA Neurology
- Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes
- (2017) Weihua Zhao et al. JAMA Neurology
- The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity
- (2016) Wenzhang Wang et al. NATURE MEDICINE
- Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients
- (2016) Eiichiro Nagata et al. PLoS One
- NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients
- (2015) Sonja Johann et al. GLIA
- Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
- (2015) C.-H. Lu et al. NEUROLOGY
- Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
- (2014) Hiroshi Mitsumoto et al. LANCET NEUROLOGY
- A Novel Acylaminoimidazole Derivative, WN1316, Alleviates Disease Progression via Suppression of Glial Inflammation in ALS Mouse Model
- (2014) Kazunori Tanaka et al. PLoS One
- A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS
- (2014) Michael E. Bozik et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset
- (2013) Osamu Kano et al. BMC Neurology
- State of play in amyotrophic lateral sclerosis genetics
- (2013) Alan E Renton et al. NATURE NEUROSCIENCE
- Inflammasomes in health and disease
- (2012) Till Strowig et al. NATURE
- Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
- (2011) David R. Beers et al. BRAIN
- Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis
- (2011) Kazunori Tanaka et al. EXPERIMENTAL NEUROLOGY
- The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus
- (2011) Yue Zhao et al. NATURE
- Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity
- (2011) Eric M. Kofoed et al. NATURE
- Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice
- (2010) David R. Beers et al. BRAIN BEHAVIOR AND IMMUNITY
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
- (2009) Petra Kaufmann et al. ANNALS OF NEUROLOGY
- Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target
- (2009) Siân C. Barber et al. FREE RADICAL BIOLOGY AND MEDICINE
- A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice
- (2008) Kazunori Tanaka et al. EXPERIMENTAL NEUROLOGY
- The NLR Gene Family: A Standard Nomenclature
- (2008) Jenny P.-Y. Ting et al. IMMUNITY
- Expression of Amyotrophic Lateral Sclerosis-linked SOD1 Mutant Increases the Neurotoxic Potential of Microglia via TLR2
- (2008) Yang Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started